Editorial: Optimizing Schools of Cytology: Discussions from the 2022 ASC/IAC Cytology Education Symposium, North American Strategies, and European Symbiosis.

Autor: Sturgis CD; Mayo Clinic Rochester, Rochester, Minnesota. Electronic address: cdsturgismd@gmail.com., LeBlanc JB; Albany College of Pharmacy and Health Sciences, Albany, New York., Smith MA; University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin., McNair SA; Memorial Sloan Kettering Cancer Center, New York, New York., Hansing KL; Mayo Clinic Rochester, Rochester, Minnesota., Bammert CE; The University of Texas MD Anderson Cancer Center, Houston, Texas., Russell DK; Daemen University, Amherst, New York., Howell JM; Indiana University School of Medicine, Indianapolis, Indiana., Alperstein SA; New York-Presbyterian Hospital, New York, New York., Lennen K; Thomas Jefferson University, Philadelphia, Pennsylvania., Srebotnik-Kirbis I; University of Ljubljana, Ljubljana, Slovenia., Paradis VA; Merkur Clinical Hospital, Zagreb, Croatia., van Zuylen-Manders L; Radboudumc, Nijmegen, the Netherlands., Liikanen E; Tampere University, Tampere, Finland., Freund G; Roswell Park Comprehensive Cancer Center, Buffalo, New York., Davey DD; University of Central Florida, Orlando, Florida., Goulart R; University of Massachusetts Chan Medical School, Worcester, Massachusetts., Yuil-Valdes A; University of Nebraska Medical Center, Omaha, Nebraska., Vielh P; American Hospital of Paris, Neuilly-sur-Seine, France., Brainard JA; Cleveland Clinic, Cleveland, Ohio., Hitchens SW; American Society of Cytopathology, Wilmington, Delaware., Donnelly A; University of Nebraska Medical Center, Omaha, Nebraska.

Publikováno v: Journal of the American Society of Cytopathology [J Am Soc Cytopathol] 2024 Jan-Feb; Vol. 13 (1), pp. 4-9. Date of Electronic Publication: 2023 Oct 25.

Optimal fluid volume for detecting malignancy in serous effusions: a single institution experience.

Autor: Beg S; Department of Pathology and Laboratory Medicine, New York Presbyterian-Weill Cornell Medicine, New York, New York., Zanettini C; Department of Pathology and Laboratory Medicine, New York Presbyterian-Weill Cornell Medicine, New York, New York., Queiroz L; Department of Pathology and Laboratory Medicine, New York Presbyterian-Weill Cornell Medicine, New York, New York; Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, State of Minas Gerais, Brazil., Marchionni L; Department of Pathology and Laboratory Medicine, New York Presbyterian-Weill Cornell Medicine, New York, New York., Alperstein SA; Department of Pathology and Laboratory Medicine, New York Presbyterian-Weill Cornell Medicine, New York, New York., Siddiqui MT; Department of Pathology and Laboratory Medicine, New York Presbyterian-Weill Cornell Medicine, New York, New York. Electronic address: mos9084@med.cornell.edu.

Publikováno v: Journal of the American Society of Cytopathology [J Am Soc Cytopathol] 2023 Nov-Dec; Vol. 12 (6), pp. 415-422. Date of Electronic Publication: 2023 Jun 13.

Evaluating the role of Z-stack to improve the morphologic evaluation of urine cytology whole slide images for high-grade urothelial carcinoma: Results and review of a pilot study.

Autor: Kim D; Division of Cytopathology, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA., Burkhardt R; Division of Cytopathology, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA., Alperstein SA; Division of Cytopathology, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA., Gokozan HN; Division of Cytopathology, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA., Goyal A; Division of Cytopathology, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA., Heymann JJ; Division of Cytopathology, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA., Patel A; Division of Cytopathology, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA., Siddiqui MT; Division of Cytopathology, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.

Publikováno v: Cancer cytopathology [Cancer Cytopathol] 2022 Aug; Vol. 130 (8), pp. 630-639. Date of Electronic Publication: 2022 May 18.

Incorporating cytologic adequacy assessment into precision oncology workflow using telepathology: An institutional experience.

Autor: Al Zoughbi W; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.; The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian Hospital, New York, New York., Kim D; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York., Alperstein SA; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.; Papanicolaou Cytology Laboratory, Weill Cornell Medicine, New York, New York., Ohara K; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.; The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian Hospital, New York, New York., Manohar J; The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian Hospital, New York, New York., Greco N; The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian Hospital, New York, New York., Khani F; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.; The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian Hospital, New York, New York., Robinson BD; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.; The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian Hospital, New York, New York., Rao RA; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York., Elemento O; The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian Hospital, New York, New York.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York., Mosquera JM; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.; The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian Hospital, New York, New York., Siddiqui MT; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.; The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian Hospital, New York, New York.; Papanicolaou Cytology Laboratory, Weill Cornell Medicine, New York, New York.

Publikováno v: Cancer cytopathology [Cancer Cytopathol] 2021 Nov; Vol. 129 (11), pp. 874-883. Date of Electronic Publication: 2021 Apr 30.

Next-Generation Sequencing of Cell-Free DNA Extracted From Pleural Effusion Supernatant: Applications and Challenges.

Autor: Patel A; Division of Cytopathology, Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, NY, United States., Hissong E; Division of Molecular and Genomic Pathology, Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, NY, United States., Rosado L; Division of Cytopathology, Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, NY, United States., Burkhardt R; Division of Cytopathology, Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, NY, United States., Cong L; Division of Molecular and Genomic Pathology, Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, NY, United States., Alperstein SA; Division of Cytopathology, Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, NY, United States., Siddiqui MT; Division of Cytopathology, Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, NY, United States., Park HJ; Clinical Genomics Laboratory, Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, NY, United States., Song W; Clinical Genomics Laboratory, Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, NY, United States., Velu PD; Division of Molecular and Genomic Pathology, Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, NY, United States., Rennert H; Division of Molecular and Genomic Pathology, Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, NY, United States., Heymann JJ; Division of Cytopathology, Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital-Weill Cornell Medical College, New York, NY, United States.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2021 Jun 14; Vol. 8, pp. 662312. Date of Electronic Publication: 2021 Jun 14 (Print Publication: 2021).